195 related articles for article (PubMed ID: 20409619)
21. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura.
Kojouri K; George JN
Int J Hematol; 2005 Feb; 81(2):119-25. PubMed ID: 15765779
[TBL] [Abstract][Full Text] [Related]
23. Dapsone for immune thrombocytopenic purpura in children and adults.
Patel AP; Patil AS
Platelets; 2015; 26(2):164-7. PubMed ID: 24512442
[TBL] [Abstract][Full Text] [Related]
24. [Idiopathic thrombocytopenic purpura in children].
Gebauer E; Vijatov G
Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
[TBL] [Abstract][Full Text] [Related]
25. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
[TBL] [Abstract][Full Text] [Related]
26. Current therapies in primary immune thrombocytopenia.
Pels SG
Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
[TBL] [Abstract][Full Text] [Related]
27. Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura.
Aggarwal A; Catlett JP
South Med J; 2002 Oct; 95(10):1209-12. PubMed ID: 12425512
[TBL] [Abstract][Full Text] [Related]
28. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
29. Dapsone for primary immune thrombocytopenia in adults and children: an evidence-based review.
Rodrigo C; Gooneratne L
J Thromb Haemost; 2013 Nov; 11(11):1946-53. PubMed ID: 23927583
[TBL] [Abstract][Full Text] [Related]
30. Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years.
Palandri F; Polverelli N; Sollazzo D; Romano M; Catani L; Cavo M; Vianelli N
Am J Hematol; 2016 Jun; 91(4):E267-72. PubMed ID: 26799593
[TBL] [Abstract][Full Text] [Related]
31. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
32. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.
Schiavotto C; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):22-8. PubMed ID: 8039754
[TBL] [Abstract][Full Text] [Related]
33. Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics.
Journeycake JM
Hematology Am Soc Hematol Educ Program; 2012; 2012():444-9. PubMed ID: 23233617
[TBL] [Abstract][Full Text] [Related]
34. Multiple cycles of rituximab therapy in chronic refractory immune thrombocytopenia: a case report with a 10-year follow-up.
Routy B; Boulassel MR; Spurll GM; Warner MN; Routy JP
Am J Ther; 2013; 20(2):219-22. PubMed ID: 23466621
[TBL] [Abstract][Full Text] [Related]
35. Management of adult idiopathic thrombocytopenic purpura.
Nakhoul IN; Kozuch P; Varma M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
[TBL] [Abstract][Full Text] [Related]
36. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.
Jovancevic B; Lindholm C; Pullerits R
Lupus; 2013 Jun; 22(7):664-74. PubMed ID: 23612795
[TBL] [Abstract][Full Text] [Related]
37. Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity.
Moulis G; Sailler L; Sommet A; Lapeyre-Mestre M; Derumeaux H; Adoue D
Am J Hematol; 2014 Jan; 89(1):41-6. PubMed ID: 24038066
[TBL] [Abstract][Full Text] [Related]
38. Rituximab for management of refractory pregnancy-associated immune thrombocytopenic purpura.
Gall B; Yee A; Berry B; Bircham D; Hayashi A; Dansereau J; Hart J
J Obstet Gynaecol Can; 2010 Dec; 32(12):1167-1171. PubMed ID: 21176329
[TBL] [Abstract][Full Text] [Related]
39. Update on the management of immune thrombocytopenic purpura in children.
Tarantino MD; Bolton-Maggs PH
Curr Opin Hematol; 2007 Sep; 14(5):526-34. PubMed ID: 17934363
[TBL] [Abstract][Full Text] [Related]
40. Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis.
Auger S; Duny Y; Rossi JF; Quittet P
Br J Haematol; 2012 Aug; 158(3):386-98. PubMed ID: 22612239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
